Bank of America
CLVS

Bank of America’s Clovis Oncology, Inc. CLVS Stock Holding History

Bank of America’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,958
Closed -$13K – 8620
2022
Q3 		$13K Buy
10,958
+1,066
+11% +$1.66K ﹤0.01% 7178
2022
Q2 		$17K Sell
9,892
-44,427
-82% -$65.5K ﹤0.01% 7235
2022
Q1 		$110K Sell
54,319
-1,468,482
-96% -$2.88M ﹤0.01% 6815
2021
Q4 		$4.13M Buy
1,522,801
+1,447,711
+1,928% +$5.35M ﹤0.01% 3846
2021
Q3 		$335K Sell
75,090
-24,168
-24% -$116K ﹤0.01% 5937
2021
Q2 		$576K Sell
99,258
-67,822
-41% -$397K ﹤0.01% 5307
2021
Q1 		$1.17M Sell
167,080
-25,490
-13% -$171K ﹤0.01% 4699
2020
Q4 		$924K Buy
192,570
+48,314
+33% +$244K ﹤0.01% 4580
2020
Q3 		$840K Sell
144,256
-192,859
-57% -$1.15M ﹤0.01% 4350
2020
Q2 		$2.27M Buy
337,115
+224,597
+200% +$1.7M ﹤0.01% 3524
2020
Q1 		$716K Sell
112,518
-131,850
-54% -$1.06M ﹤0.01% 4247
2019
Q4 		$2.55M Buy
244,368
+26,448
+12% +$192K ﹤0.01% 3834
2019
Q3 		$857K Sell
217,920
-255,191
-54% -$2.06M ﹤0.01% 4663
2019
Q2 		$7.04M Buy
473,111
+136,241
+40% +$2.46M ﹤0.01% 2894
2019
Q1 		$8.36M Buy
336,870
+118,581
+54% +$2.97M ﹤0.01% 2667
2018
Q4 		$3.92M Sell
218,289
-238,030
-52% -$4.86M ﹤0.01% 3252
2018
Q3 		$13.4M Sell
456,319
-126,815
-22% -$4.91M ﹤0.01% 2168
2018
Q2 		$26.5M Buy
583,134
+242,707
+71% +$11.8M ﹤0.01% 1584
2018
Q1 		$18M Sell
340,427
-442,710
-57% -$25.8M ﹤0.01% 1865
2017
Q4 		$53.3M Buy
783,137
+241,244
+45% +$16.9M 0.01% 1048
2017
Q3 		$44.7M Sell
541,893
-105,282
-16% -$8.35M 0.01% 1242
2017
Q2 		$60.6M Buy
647,175
+471,290
+268% +$28.8M 0.01% 927
2017
Q1 		$11.2M Buy
175,885
+157,618
+863% +$9.58M ﹤0.01% 2282
2016
Q4 		$811K Sell
18,267
-312,397
-94% -$11M ﹤0.01% 4489
2016
Q3 		$11.9M Buy
330,664
+323,424
+4,467% +$6.94M ﹤0.01% 2081
2016
Q2 		$99K Buy
7,240
+6,490
+865% +$94.9K ﹤0.01% 5530
2016
Q1 		$14K Sell
750
-26,162
-97% -$554K ﹤0.01% 6282
2015
Q4 		$942K Buy
26,912
+17,872
+198% +$1.15M ﹤0.01% 4409
2015
Q3 		$832K Sell
9,040
-585
-6% -$50.6K ﹤0.01% 4467
2015
Q2 		$846K Buy
9,625
+7,020
+269% +$601K ﹤0.01% 4242
2015
Q1 		$193K Sell
2,605
-2,973
-53% -$210K ﹤0.01% 4948
2014
Q4 		$312K Buy
5,578
+156
+3% +$8.2K ﹤0.01% 5004
2014
Q3 		$246K Sell
5,422
-4,737
-47% -$198K ﹤0.01% 5205
2014
Q2 		$421K Sell
10,159
-17,109
-63% -$881K ﹤0.01% 4785
2014
Q1 		$1.89M Sell
27,268
-1,458
-5% -$107K ﹤0.01% 3270
2013
Q4 		$1.73M Sell
28,726
-883
-3% -$48K ﹤0.01% 3465
2013
Q3 		$1.8M Buy
29,609
+1,267
+4% +$89.9K ﹤0.01% 3371
2013
Q2 		$1.9M Buy
+28,342
New +$1.27M ﹤0.01% 3271

Other funds holding CLVS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
FFWM
Future Financial Wealth Management Cincinnati, Ohio $160M AUM 21.24% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Bank of America's CLVS Position: Q4 2022 in Review

Bank of America sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 10,958 shares — an estimated $13K sold.

Bank of America first reported a position in CLVS in Q2 2013 and held it in 38 quarters. The position peaked at $60.6M in Q2 2017. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • Bank of America reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • Bank of America sold 10,958 Clovis Oncology, Inc. shares in Q4 2022, an estimated $13K.
  • Bank of America first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 38 quarters.
  • Bank of America's Clovis Oncology, Inc. position peaked at $60.6M in Q2 2017.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Bank of America's 13F filing for Q4 2022, filed 10 Feb 2023.